Research Presentation Sessions: GI Tract
RPS 1001b - Novelties in hepatobiliary imaging
Lectures
1
Introduction by the moderator
02:00Federica Vernuccio, Padova / IT
2
Is there any role for multiparametric MRI of the liver in follow-up of liver-transplant patients?
08:00Benjamin Henninger, Innsbruck / AT
3
Golden-angle radial sparse parallel dynamic contrast enhanced MRI: automatic detection and characterisation of liver lesions using contrast agent behaviour
08:00Manfred Meyer, Basel / CH
4
Quantification of hepatic steatosis with a novel attenuation imaging (ATI) ultrasound technique (QAI): preliminary findings on feasibility, reproducibility and diagnostic accuracy
08:00Matteo Garcovich, Rome / IT
5
Virtual portal vein pressure gradient based on CFD model: a noninvasive procedure with CT angiography for the diagnosis of portal hypertension
08:00Shang Wan, Cheng DU / CN
6
Prediction of hepatic decompensation in patients with primary sclerosing cholangitis using body composition model and machine learning-based combined topological and radiomics features
08:00Yashbir Singh, Rochester / US
7
Assessment of clinical outcome in patients with portal hypertension: quantitative computed tomographic feature may serve as an effective biomarker
08:00Shang Wan, Cheng DU / CN
8
Development and assessment of prognostic value and agreement of a novel MRCP-score for patients with primary sclerosing cholangitis
08:00Aristeidis Grigoriadis, Stockholm / SE
9
Early tumour shrinkage as a novel imaging biomarker for patients with hepatocellular carcinoma undergoing immunotherapy
08:00Felix Hahn, Mainz / DE
10
Evaluation of various methods of liver measurement in comparison to volumetric segmentation based on computed tomography
08:00Maciej Cebula, Katowice / PL
11
The role of splenic volume as imaging biomarker in patients with hepatocellular carcinoma under immunotherapy
08:00Felix Hahn, Mainz / DE
12
Myosteatosis can predict unfavourable outcomes in advanced hepatocellular carcinoma patients treated with hepatic artery infusion chemotherapy and anti-PD-1 immunotherapy
08:00Xiaoping Yi, Changsha / CN
